Chiasma Inc Revenue per Employee (CHMA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Chiasma Inc   (NASDAQ: CHMA)
 

Chiasma Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Chiasma Inc 's Revenue per employee grew on a trailing twelve month basis to $ 34,828, above the company average.
Within the Healthcare sector Chiasma Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Chiasma Inc has 87 employees.


What is Sales per Employee Ratio?







CHMA Revenue per Employee (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 34,828 12,713 1,632 - -
CHMA's Total Ranking # # # # #
Seq. Revenue Change 99.59 % 578.87 % - - -


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 0 $ 0 $ 0
 



Financial Statements
Chiasma Inc 's Revenue MRQ $ 2 Millions Visit CHMA's Income Statement
Chiasma Inc 's Revenues TTM $ 3 Millions Visit CHMA's aggregate revenue growth
What are CHMA's Sales? Visit CHMA's Sales by Segment




Other Ratios
Chiasma Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CHMA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CHMA's Competitors
Revenue per Employee for CHMA's Suppliers
Revenue per Employee for CHMA's Customers

You may also want to know
CHMA's Sales Growth Rates CHMA's Pe Price to earnings ratio CHMA's Receivables Turnover Ratio CHMA's Stock Quote
CHMA's Net Income Growth Rates CHMA's Ps Price to Sales ratio CHMA's Sales per Employee CHMA's Asset Turnover Ratio
CHMA's Net Margin CHMA's Pb Price to Book ratio CHMA's Financial Strength Ratios CHMA's Dividend Payout Ratio
Date modified: 2026-09-08T15:10:15+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2021, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2021Number of Employees Mar 31 2021
Neximmune Inc   60,621.93 $ 2.425  Million 40 
Igc Pharma Inc   59,866.67 $ 0.898  Million 15 
Acutus Medical Inc   58,868.85 $ 3.591  Million 61 
Perspective Therapeutics Inc   57,963.86 $ 9.622  Million 166 
U S Physical Therapy Inc  57,940.77 $ 422.620  Million 7,294 
Lakeland Industries Inc   56,734.62 $ 147.510  Million 2,600 
Finch Therapeutics Group Inc   56,396.83 $ 3.553  Million 63 
Dbv Technologies S a   55,864.71 $ 9.497  Million 170 
Dariohealth Corp   54,412.12 $ 8.978  Million 165 
Intelgenx Technologies Corp   54,266.67 $ 1.628  Million 30 
Neuropace Inc   53,669.86 $ 11.217  Million 209 
Revance Therapeutics Inc   53,494.38 $ 28.566  Million 534 
Ensign Group Inc  53,048.61 $ 2,440.236  Million 46,000 
Scholar Rock Holding Corp  52,183.39 $ 15.081  Million 289 
China Pharma Holdings Inc  51,859.12 $ 11.461  Million 221 
Mymetics Corporation  49,466.67 $ 0.594  Million 12 
Electrocore Inc   47,781.99 $ 3.966  Million 83 
Healthcare Services Group Inc   47,747.33 $ 1,718.904  Million 36,000 
Revolution Medicines Inc   47,075.88 $ 41.568  Million 883 
Dermtech Inc   46,297.30 $ 6.852  Million 148 
Scientific Industries Inc   46,030.20 $ 9.298  Million 202 
Myomo Inc   45,701.10 $ 8.912  Million 195 
Star Equity Holdings Inc   45,660.83 $ 54.793  Million 1,200 
Baudax Bio Inc   43,187.50 $ 0.691  Million 16 
Infinity Pharmaceuticals Inc   42,878.05 $ 1.758  Million 41 
Bionik Laboratories Corp   42,622.50 $ 1.193  Million 28 
Imac Holdings Inc   41,926.32 $ 12.578  Million 300 
The Pennant Group Inc   41,728.56 $ 404.767  Million 9,700 
Treace Medical Concepts Inc   41,571.11 $ 18.707  Million 450 
Inhibikase Therapeutics Inc   40,204.71 $ 1.407  Million 35 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.